C12Y 401/99017
Phosphomethylpyrimidine synthase
Official title: Phosphomethylpyrimidine synthase (4.1.99.17)
C12Y401/99017 (Phosphomethylpyrimidine synthase) appears on 3 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 6
- Assignees
- 4
- Inventors
- 14
- Latest grant
- 26 Dec 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Cell factory having improved iron-sulfur cluster delivery26 Dec 2023US 11,851,461 B2Biosyntia Aps
- Genetically modified bacterial cell factory for thiamine production30 Jun 2020US 10,696,992 B2Biosynthia Aps
- Vitamin prototrophy as a selectable marker17 Sep 2019US 10,415,043 B2Lanzatech New Zealand Limited
- Microbial cell factories producing thiamine22 Jan 2026US 2026/0022411 A1
- Cell factory having improved iron-sulfur cluster delivery22 Jun 2023US 2023/0192778 A1Biosyntia Aps
- Cell factories for improved production of compounds and proteins dependent on iron sulfur clusters28 Apr 2022US 2022/0127311 A1Biosyntia Aps
- A genetically modified bacterial cell factory for thiamine production19 Dec 2019US 2019/0382815 A1Biosyntia Aps
- Vitamin prototrophy as a selectable marker19 Jan 2017US 2017/0016007 A1Lanzatech New Zealand Limited
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.